Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health Catalyst (HCAT) Interest Expenses (2018 - 2023)

Health Catalyst (HCAT) has disclosed Interest Expenses for 6 consecutive years, with -$2.6 million as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Interest Expenses fell 155.97% year-over-year to -$2.6 million, compared with a TTM value of -$2.6 million through Sep 2024, up 65.18%, and an annual FY2023 reading of -$9.1 million, down 642.67% over the prior year.
  • Interest Expenses was -$2.6 million for Q4 2023 at Health Catalyst, roughly flat from -$2.6 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $4.4 million in Q3 2021 and bottomed at -$2.6 million in Q4 2023.
  • Average Interest Expenses over 5 years is $1.2 million, with a median of $1.1 million recorded in 2019.
  • The sharpest move saw Interest Expenses surged 722.63% in 2020, then tumbled 1735.92% in 2023.
  • Year by year, Interest Expenses stood at $495000.0 in 2019, then soared by 722.63% to $4.1 million in 2020, then grew by 7.47% to $4.4 million in 2021, then tumbled by 123.35% to -$1.0 million in 2022, then plummeted by 155.97% to -$2.6 million in 2023.
  • Business Quant data shows Interest Expenses for HCAT at -$2.6 million in Q4 2023, -$2.6 million in Q3 2023, and -$2.1 million in Q2 2023.